ORIC
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. (ORIC) has 3 SEC Form 4 filings (6 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 28, 2026.
Insiders have net sold $864K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Jacob Chacko
- Employees:122
- HQ:South San Francisco, CA, US
- IPO:2020-04-24
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$864K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$1.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 13,100 | $157K | Jul 28 | SEC ↗ | |
Heyman Richard A.First in 5 months | Director | Sale | 300 | $4K | Jul 8 | SEC ↗ |
Piscitelli DominicFirst filing | Chief Financial Officer | Sale | 52,000 | $703K | Feb 26 | SEC ↗ |
Related companies
Oric Pharmaceuticals, Inc. is in the Healthcare sector.